Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension

PHASE2CompletedINTERVENTIONAL

Enrollment

441

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

July 31, 2010

Conditions

Essential Hypertension

Interventions

DRUG

Lercanidipine + Valsartan

L10/V80, L20/V80, L10/V160, L20/V160

DRUG

Lercanidipine or Valsartan

L10, L20, V80, V160

DRUG

Placebo

Placebo of Lercanidipine and Valsartan

Trial Locations (2)

Seoul National University Hospital, Seoul

23 sites in Korea, Seoul, Busan Etc.